Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: Preventive testing for 3 months

Bone

Volumn 22, Issue 2, 1998, Pages 119-124

  Kasugai, Y ^a   Ikegami, A ^a   Matsuo, K ^a   Ohashi, M ^b   Sukamoto, T ^a   Hosoi, T ^c   Ouchi, Y ^c   Orimo, H ^d  

^a KANEBO LTD   (Japan)

^b New Drug Research Laboratories   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Ministry of Finance   (Japan)

Author keywords

Bone mineral density; Estrogen; Low Ca diet; Osteopenia; Ovariectomy; Tibolone

Indexed keywords

CHOLESTEROL; CREATININE; OSTEOCALCIN; PYRIDINOLINE; STEROID; TIBOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; BONE STRENGTH; CALCIUM INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG EFFECT; FEMALE; FEMUR; HYDROXYPROLINE URINE LEVEL; INTRAGASTRIC DRUG ADMINISTRATION; LUMBAR VERTEBRA; NONHUMAN; OSTEOPENIA; OVARIECTOMY; PROTEIN BLOOD LEVEL; RAT; UTERUS WEIGHT; WEIGHT GAIN;

ADMINISTRATION, ORAL; AMINO ACIDS; ANABOLIC AGENTS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; CALCIUM; CHOLESTEROL; CREATININE; FEMALE; FEMUR; HUMANS; HYDROXYPROLINE; LUMBAR VERTEBRAE; NORPREGNENES; OSTEOCALCIN; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT GAIN;

EID: 0031974385     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00254-8     Document Type: Article

References (37)

1. Allain C. C., Poon L. S., Chan C. S. G., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475.
2. Berning B., Kuijk C. V., Kuiper J. W., Coelingh Bennink H. J. T., Kicovic P. M., Fauser B. C. J. M. Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women A two-year randomized placebo-controlled study . Bone. 19:1996;395-399.
3. Böhlen P., Mellet M. Automated fluorometric amino acid analysis The determination of proline and hydroxyproline . Anal Biochem. 94:1979;313-321.
4. Bull L. S., Hurley W. L., Kennett W. S., Tamplin C. B., Williams W. F. Effect of sex hormones on feed intake in rats. J Nutr. 104:1974;968-975.
5. Buring J. E., Bain C. J., Ehrmann R. L. Conjugated estrogen use and risk of endometrial cancer. Am J Epidemiol. 124:1986;434-441.
6. Cittadini J., Ben J., Badano A. R., Denari H. J., Quiroga S., Marcus A. E., Schlaen I., Casas P. R. F. The use of a new steroid (Org OD 14) in the climacteric syndrome. Reproduccion. 6:1982;69-79.
7. Christiansen C., Christensen M. S., Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet. 28:1981;459-461.
8. De Aloysio D., Fabiani A. G., Mauloni M., Bottiglioni F. Use of Org OD 14 for the treatment of climacteric complaints. Maturitas. (Suppl. 1):1987;49-65.
9. de Visser J., Coert A., Feenstra H., van der Vies J. Endocrinological studies with (7α, 17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14). Arzneim-Forsch/Drug Res. 34:1984;1010-1017.
10. de Vries E. C. P., de Rijk E. P. C. T., Ederveen A. G. H. J., Kloosterboer H. J. The effect of Org OD 14 on bone loss in young and old ovariectomized rats. Eur J Endocrinol. (Suppl. 2):1994;S24.06.
11. Devlin H., Ferguson M. W. J. Compositional changes in the rat femur following ovariectomy. Acta Anat. 136:1989;38-41.
12. Frolik C. A., Bryant H. U., Black E. C., Magee D. E., Chandrasekhar S. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats Effects of raloxifene HCl, tamoxifen, estrogen, and alendronate . Bone. 18:1996;621-627.
13. Genazzani A. R., Benedek-Jaszmann L. J., Hart D. M., Andolsek L., Kivioc P. M., Tax L. Org OD 14 and the endometrium. Maturitas. 13:1991;243-251.
14. Grodstein F., Stampfer M. J., Manson J. E., Colditz G. A., Willett W. C., Rosner B., Speizer F. F., Hennekens C. H. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 335:1996;453-461.
15. Hodgkinson A., Aaron J., Horsman A., McLachlan M. S. F., Nordin B. E. C. Effect of oophorectomy and calcium deprivation on bone mass in the rat. Clin Sci Mol Med. 54:1978;439-446.
16. Horsman A., Jones M., Francis R., Nordin C. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med. 309:1983;1405-1407.
17. Kalu D. N., Liu C.-C., Hardin R. R., Hollis B. W. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology. 124:1989;7-16.
18. Kalu D. N., Liu C.-C., Salerno E., Hollis B., Echon R., Ray M. Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner. 14:1991;175-187.
19. Kicovic P. M., Cortes-Prieto J., Luisi M., Milojevic S., Franchi F. Placebo-controlled crossover study of effects of Org OD 14 in menopausal women. Reproduccion. 6:1982;81-91.
20. Lindgren J. U., Lindholm T. S. Effect of 1-α-hydroxyvitamin D3 on osteoporosis in rats induced by oophorectomy. Calcif Tiss Int. 27:1979;161-164.
21. Lindsay R., Hart D. M., Kraszewski A. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J. 280:1980;1207-1209.
22. Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 294:1976;1262-1267.
23. Motoie H., Nakamura T., O'uchi N., Nishikawa H., Kanoh H., Abe T., Kawashima H. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction. J Bone Miner Res. 10:1995;910-920.
24. Otawara Y., Sakaguchi C., Hosoya N., Kuwada M., Katayama K., Ishiguro S., Moriuchi S. Determination of vitamin K-dependent calcium binding protein level in rat bone using radioimmunoassay and high-performance liqid chromatography. Vitamins. 15:1982;531-535.
25. Peck W. A., Riggs B. L., Bell N. H., Wallace R. B., Johnston C. C., Gordon S. L., Shulman L. E. Research directions in osteoporosis. Scientific Workshop. Am J Med. 84:1988;275-282.
26. Price P. A., Parthemore J. G., Deftos L. J. New biochemical marker for bone metabolism. J Clin Invest. 66:1980;878-883.
27. Riggs B. L., Melton L. J. III. Involutional osteoporosis. N Engl J Med. 314:1986;1676-1686.
28. Riggs B. L., Wahner H. W., Seeman E., Offord K. P., Dunn W. L. Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest. 70:1982;716-723.
29. Rymer J., Crook D., Sidhu M., Chapman M., Stevenson J. C. Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women. Acta Endocrinol. 128:1993;259-262.
30. Shen V., Birchman R., Xu R., Lindsay R., Dempster D. W. Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen- and/or dietary calcium-deficient rats. Bone. 16:1995;149-156.
31. Steinberg K. K., Thacker S. B., Jay Smith S., Stroup D. F., Zack M. M., Flanders W. D., Berkelman R. L. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. J Am Med Assoc. 265:1991;1985-1990.
32. Tang B., Markiewicz L., Kloosterboer H. J., Gurpide E. Human endometrial 3β-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14). J Steroid Biochem Molec Biol. 45:1993;345-351.
33. Tax L., Goorissen E. M., Kicovic P. M. Clinical profile of Org OD 14. Maturitas. (Suppl. 1):1987;3-13.
34. Tsutsumi N., Kawashima K., Nagata H., Tsuyuki J., Itoh F., Arai N., Kojima M., Ujiie A., Endo H. Effects of KCA-098 on bone metabolism Comparison with those of ipriflavone . Jpn J Pharmacol. 65:1994;343-349.
35. van der Vies J. Pharmacological studies with (7α, 17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14). Maturitas. (Suppl. 1):1987;15-24.
36. Windler E. E. T., Kovanen P. T., Chao Y.-S., Brown M. S., Have R. J., Goldstein J. L. The estradiol-stimulated lipoprotein receptor of rat liver. J Biol Chem. 255:1980;10464-10471.
37. Yoshimura Y., Ohnishi K., Hamamura M. Automated high-performance liquid chromatographic determination of hydroxylysylpyridinoline and lysylpyridinoline in urine using a column-switching method. J Chromatogr. 613:1993;43-49.